Close Menu

NEW YORK (GenomeWeb) – The European Organisation for Treatment of Cancer and 14M Genomics today announced a collaboration to use genomic profiling for enrollment into cancer clinical trials.

Under the terms of the agreement, 14M Genomics will analyze genomic variation of patients newly diagnosed with colorectal, thoracic, brain, and skin cancers for the EORTC Screening Patients for Efficient Clinical Trial Access (SPECTA) program.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.